Inhibition of dipeptidyl peptidase-4 (DPP4), antioxidant, antiglycation and anti-inflammatory effect of Ferulic acid against streptozotocin toxicity mediate nephropathy in diabetic rats

被引:0
|
作者
Maryam A. AL-Ghamdi
Said S. Moselhy
机构
[1] King Abdulaziz University (KAU),Department of Biochemistry, Faculty of Science
[2] King Abdulaziz University (KAU),Vitamin D Pharmacogenomics Research Group
[3] King Abdulaziz University (KAU),Experimental Biochemistry Unit, King Fahd Medical Research Center
[4] Ain Shams University,Department of Biochemistry, Faculty of Science
关键词
Ferulic acid; Diabetic; DPP4; Nephropathy; Inflammation; AGES;
D O I
暂无
中图分类号
学科分类号
摘要
The protein glycation due to high blood glucose mediate release of inflammatory intermediate contributes in the development of diabetic nephropathy. Ferulic acid (FA) is a phenolic compound distributed in different foods as whole grains. Inhibitors of DPP4 improve GLP-1-mediated insulin secretion and inhibit liver gluconeogenesis. This study investigated the impact of FA as anti-inflammatory, antioxidant and antiglycation against streptozotocin-induced diabetic nephropathy in rats. This study was carried out on total ninety male rats allocated into six (each 15 rats); group I (control). All other animals (groups II–VI) were receiving 65 mg/kg STZ for induction of diabetes. Rats in group II (untreated diabetic). Rats in groups III–V were treated with FA (10, 20, 30 mg/kg bw) respectively, i.p. for 8 weeks. Group VI received 10 units insulin daily, sc. Fasting blood samples were subjected for assay of glycated hemoglobin (HA1c), serum MDA, aldose reductase, total antioxidant, DPP4 while kidney tissue subjected for assay of malondialdehyde (MDA), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (SOD), tumor necrosis factor-α (TNF-α), IL-1β and AGEs. Data obtained showed that, FA showed antioxidant activity by reducing MDA and enhancement antioxidant activity compared with untreated rats (p < 0.001) with dose dependence. In addition, FA reduced the activities of aldose reductase, DPP4 (p < 0.001), decreased IL-6, TNF-α and AGEs versus untreated rats (p < 0.001). Histological investigation revealed an improvement in the nephron structure in diabetic rat treated with FA versus untreated group. It was concluded that, FA possesses a potent antioxidant and anti-inflammatory and DPP4 inhibitor. For that, it was considered as a protective agent against the risk of diabetic nephropathy and can be used as alternative or complementary supplement.
引用
收藏
页码:33942 / 33948
页数:6
相关论文
共 18 条
  • [1] Inhibition of dipeptidyl peptidase-4 (DPP4), antioxidant, antiglycation and anti-inflammatory effect of Ferulic acid against streptozotocin toxicity mediate nephropathy in diabetic rats
    Al-Ghamdi, Maryam A.
    Moselhy, Said S.
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2023, 30 (12) : 33942 - 33948
  • [2] Sitagliptin, an anti-diabetic drug, inhibits the pro-inflammatory microglia reactivity via dipeptidyl peptidase-4 (DPP4)
    Leger, Helene
    Leote, Cristiana
    Bufano, Lucia
    Boia, Raquel
    Santiago, Ana Raquel
    Fernandes, Rosa
    Ambrosio, Antonio Francisco
    ACTA OPHTHALMOLOGICA, 2024, 102
  • [3] In Silico Study Of Four Alkaloids As Dipeptidyl Peptidase-4 (Dpp4) Inhibitors To Generate Anti-Diabetics Effect.
    Alzahrani, Abdulaziz
    EGYPTIAN JOURNAL OF CHEMISTRY, 2023, 66 (02): : 471 - 477
  • [4] Oxygen scavenging, anti-inflammatory, and antiglycation activity of pomegranate flavonoids (Punica granum) against streptozotocin toxicity induced diabetic nephropathy in rats
    Mosaoa, Rami M.
    Yaghmoor, Soonham S.
    Moselhy, Said S.
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2023, 30 (06) : 16687 - 16693
  • [5] Oxygen scavenging, anti-inflammatory, and antiglycation activity of pomegranate flavonoids (Punica granum) against streptozotocin toxicity induced diabetic nephropathy in rats
    Rami M. Mosaoa
    Soonham S. Yaghmoor
    Said S. Moselhy
    Environmental Science and Pollution Research, 2023, 30 : 16687 - 16693
  • [6] Anti-inflammatory effect of dipeptidyl peptidase 4 inhibitors in the treatment of diabetic cardiovasculopathy
    Zhao, Ruxing
    Hou, Xinguo
    Chen, Li
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35
  • [7] ANTI-INFLAMMATORY EFFECTS OF DIPEPTIDYL PEPTIDASE-4 INHIBITION ON HUMAN LUNG MICROVASCULAR ENDOTHELIAL CELLS
    Kawasaki, T.
    Meliton, L.
    Wang, L.
    Epshtein, Y.
    Tatsumi, K.
    Dudek, S. M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (04) : 867 - 868
  • [8] A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients
    Satoh-Asahara, Noriko
    Sasaki, Yousuke
    Wada, Hiromichi
    Tochiya, Mayu
    Iguchi, Azusa
    Nakagawachi, Reiko
    Odori, Shinji
    Kono, Shigeo
    Hasegawa, Koji
    Shimatsu, Akira
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (03): : 347 - 351
  • [9] Anti-Hyperlipidemic, Antioxidant, Anti-Inflammatory and Antidiabetic Effect of Brucine Against Streptozotocin-Induced Diabetic Nephropathy in Rats
    Feng, Ling
    Gao, Lei
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2025, 39 (01)
  • [10] Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats
    Kirino, Yasushi
    Sato, Youichi
    Kamimoto, Takayuki
    Kawazoe, Kazuyoshi
    Minakuchi, Kazuo
    Nakahori, Yutaka
    JOURNAL OF ENDOCRINOLOGY, 2009, 200 (01) : 53 - 61